Swiss National Bank Buys 800 Shares of Omnicell, Inc. (NASDAQ:OMCL)

Swiss National Bank boosted its position in Omnicell, Inc. (NASDAQ:OMCL) by 0.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 90,500 shares of the company’s stock after acquiring an additional 800 shares during the period. Swiss National Bank’s holdings in Omnicell were worth $4,029,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Smartleaf Asset Management LLC boosted its position in Omnicell by 51.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock worth $35,000 after purchasing an additional 273 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Omnicell by 47.0% in the 4th quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock valued at $44,000 after acquiring an additional 315 shares during the period. First Horizon Advisors Inc. boosted its stake in shares of Omnicell by 36.3% in the fourth quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock valued at $59,000 after purchasing an additional 355 shares during the period. Redmond Asset Management LLC grew its position in shares of Omnicell by 0.3% during the fourth quarter. Redmond Asset Management LLC now owns 121,209 shares of the company’s stock worth $5,396,000 after buying an additional 371 shares in the last quarter. Finally, KBC Group NV raised its position in shares of Omnicell by 60.8% during the 4th quarter. KBC Group NV now owns 2,057 shares of the company’s stock worth $92,000 after acquiring an additional 778 shares in the last quarter. Institutional investors and hedge funds own 97.70% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OMCL. Wells Fargo & Company decreased their target price on shares of Omnicell from $49.00 to $40.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. StockNews.com downgraded Omnicell from a “buy” rating to a “hold” rating in a report on Monday. JPMorgan Chase & Co. cut their price objective on shares of Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday, March 20th. Bank of America dropped their target price on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating on the stock in a report on Monday, January 6th. Finally, Benchmark reaffirmed a “buy” rating and set a $62.00 target price on shares of Omnicell in a research note on Tuesday, February 4th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $51.00.

Omnicell Stock Down 1.9 %

OMCL opened at $34.47 on Wednesday. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of 127.67, a PEG ratio of 7.53 and a beta of 0.85. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.22 and a current ratio of 1.37. The firm’s 50-day simple moving average is $39.47 and its 200-day simple moving average is $42.75. Omnicell, Inc. has a twelve month low of $25.12 and a twelve month high of $55.75.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. Equities research analysts anticipate that Omnicell, Inc. will post 1.09 EPS for the current fiscal year.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.